Day One Biopharmaceuticals Ownership | Who Owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals Ownership Summary
Day One Biopharmaceuticals is owned by 94.97% institutional investors, 16.98% insiders. Ra capital management is the largest institutional shareholder, holding 9.08% of DAWN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.44% of its assets in Day One Biopharmaceuticals shares.
DAWN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Day One Biopharmaceuticals | 94.97% | 16.98% | -11.95% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 7.87M | 9.08% | $108.47M |
| Atlas venture life science advisors | 6.43M | 7.42% | $88.61M |
| Vanguard group | 4.62M | 5.33% | $63.71M |
| Blackrock | 4.53M | 5.23% | $62.47M |
| Franklin resources | 3.78M | 4.36% | $52.12M |
| Braidwell lp | 3.04M | 3.50% | $41.83M |
| Deerfield management company, l.p. (series c) | 2.92M | 3.37% | $40.28M |
| Pictet asset management sa | 2.85M | 3.29% | $39.29M |
| State street | 2.83M | 3.26% | $38.95M |
| Fmr | 2.66M | 3.07% | $36.67M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Estuary capital management lp | 2.64M | 11.71% | $36.31M |
| Atlas venture life science advisors | 6.43M | 9.33% | $88.61M |
| Dafna capital management | 666.46K | 2.19% | $9.18M |
| Parkman healthcare partners | 908.82K | 1.68% | $12.52M |
| Ra capital management | 7.87M | 1.43% | $108.47M |
| Braidwell lp | 3.04M | 1.31% | $41.83M |
| Vestal point capital, lp | 1.25M | 1.28% | $17.23M |
| Boxer capital | 1.19M | 0.86% | $16.40M |
| Deerfield management company, l.p. (series c) | 2.92M | 0.67% | $40.28M |
| Sphera funds management | 347.63K | 0.65% | $4.79M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 1.25M | 1.28% | 1.25M |
| Deerfield management company, l.p. (series c) | 2.92M | 0.67% | 1.16M |
| Estuary capital management lp | 2.64M | 11.71% | 1.02M |
| Braidwell lp | 3.04M | 1.31% | 862.20K |
| Pictet asset management sa | 2.85M | 0.04% | 476.44K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 2.66M | 0.00% | -1.74M |
| First turn management | - | - | -1.32M |
| Ally bridge group (ny) | - | - | -536.10K |
| Blackrock | 4.53M | 0.00% | -497.99K |
| Point72 asset management | - | - | -470.25K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vestal point capital, lp | 1.25M | 1.28% | 1.25M | $17.23M |
| Kennedy capital management | 173.74K | 0.05% | 173.74K | $2.39M |
| Norges bank | 169.00K | 0.00% | 169.00K | $2.33M |
| Two sigma advisers, lp | 84.30K | 0.00% | 84.30K | $1.16M |
| Renaissance | 72.14K | 0.00% | 72.14K | $994.09K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Northwestern mutual wealth management | -14.00 |
| Smartleaf asset management | -19.00 |
| Carsonallaria wealth management | -180.00 |
| Entrypoint capital | -582.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 174 | 6.10% | 91,763,456 | 23.09% | 94 | 1.30% | 102 | 27.50% | 37 | -22.92% |
| Jun 30, 2024 | 163 | 10.14% | 74,549,937 | 2.96% | 86 | 1.04% | 80 | 11.11% | 47 | 9.30% |
| Mar 31, 2024 | 148 | 7.25% | 72,408,321 | -5.35% | 90 | 1.15% | 72 | -4.00% | 43 | 26.47% |
| Dec 31, 2023 | 138 | 6.98% | 76,499,376 | -1.29% | 89 | 0.83% | 75 | 8.70% | 34 | 3.03% |
| Sep 30, 2023 | 129 | -9.79% | 77,496,532 | -1.71% | 103 | 0.86% | 69 | -29.59% | 33 | 43.48% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.46M | 2.44% | 3.47K |
| Pictet-Biotech P USD | 1.70M | 1.68% | -9.33K |
| US Small-Cap Growth II Equity Comp | 1.54M | 1.57% | 115.04K |
| T. Rowe Price New Horizons | 1.54M | 1.57% | -156.94K |
| SPDR® S&P Biotech ETF | 1.50M | 1.49% | 16.66K |
| Franklin Biotechnology Discv A(acc)USD | 1.47M | 1.46% | - |
| Franklin US Small Cap Growth Equity | 1.40M | 1.42% | 223.17K |
| Franklin Small Cap Growth Adv | 1.40M | 1.42% | - |
| Pictet Biotech | 1.37M | 1.40% | 1.37M |
| iShares Russell 2000 ETF | 1.33M | 1.32% | -2.98K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2024 | Blackman Samuel C. | HEAD OF R&D | Sell | $399.34K |
| Nov 18, 2024 | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | $139.42K |
| Nov 18, 2024 | Blackman Samuel C. | HEAD OF R&D | Sell | $29.14K |
| Nov 18, 2024 | Dubow Adam | GENERAL COUNSEL | Sell | $41.81K |
| Nov 18, 2024 | York Charles N II | COO, CFO AND SECRETARY | Sell | $34.37K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 9 |
| 2024 Q3 | 1 | 6 |
| 2024 Q2 | - | 14 |
| 2024 Q1 | - | 7 |
| 2023 Q4 | 3 | 4 |
DAWN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools